1 Wallentin L, "Ticagrelor versus clopidogrel in patients with acute coronary syndromes" 361 : 1045-1057, 2009
2 Montalescot G, "TRITON-TIMI 38 investigators. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITONTIMI 38): double-blind, randomised controlled trial" 373 : 723-731, 2009
3 Wiviott SD, "TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes" 357 : 2001-2015, 2007
4 Lassen MR, "RECORD3 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty" 358 : 2776-2786, 2008
5 Connolly SJ, "RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation" 361 : 1139-1151, 2009
6 van de Beek D, "Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis" 66 : 1076-1081, 2009
7 O’Donoghue ML, "Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials" 374 : 989-997, 2009
8 Wiviott SD, "PRINCIPLE-TIMI 44 Investigators. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation- Thrombolysis in Myocardial Infarction 44 trial" 116 : 2923-2932, 2007
9 den Hertog HM, "PAIS Investigators. The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial" 8 : 434-440, 2009
10 Diener HC, "MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial" 364 : 331-337, 2004
1 Wallentin L, "Ticagrelor versus clopidogrel in patients with acute coronary syndromes" 361 : 1045-1057, 2009
2 Montalescot G, "TRITON-TIMI 38 investigators. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITONTIMI 38): double-blind, randomised controlled trial" 373 : 723-731, 2009
3 Wiviott SD, "TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes" 357 : 2001-2015, 2007
4 Lassen MR, "RECORD3 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty" 358 : 2776-2786, 2008
5 Connolly SJ, "RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation" 361 : 1139-1151, 2009
6 van de Beek D, "Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis" 66 : 1076-1081, 2009
7 O’Donoghue ML, "Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials" 374 : 989-997, 2009
8 Wiviott SD, "PRINCIPLE-TIMI 44 Investigators. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation- Thrombolysis in Myocardial Infarction 44 trial" 116 : 2923-2932, 2007
9 den Hertog HM, "PAIS Investigators. The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial" 8 : 434-440, 2009
10 Diener HC, "MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial" 364 : 331-337, 2004
11 Simon T, "French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators. Genetic determinants of response to clopidogrel and cardiovascular events" 360 : 363-375, 2009
12 Taylor AJ, "Extended-release niacin or ezetimibe and carotid intima-media thickness" 361 : 2113-2122, 2009
13 ACTIVE Investigators, "Effect of clopidogrel added to aspirin in patients with atrial fibrillation" 360 : 2066-2078, 2009
14 Collet JP, "Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study" 373 : 309-317, 2009
15 Bhatt DL, "CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events" 354 : 1706-1717, 2006
16 Mega JL, "ATLAS ACS-TIMI 46 study group. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial" 374 : 29-38, 2009